Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
|萊姆病檢驗(體外診斷)-全球市場分析及預測模式(COVID-19對市場造成的影響) Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)|
|出版日期: 2020年10月30日||內容資訊: 英文||
網羅的企業:PerkinElmer Inc，bioMerieux SA，Meridian Bioscience Inc，Bio-Rad Laboratories Inc，Thermo Fisher Scientific Inc，其他
Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Lyme disease Tests market for the year 2020 and beyond. Lyme disease is an inflammatory disease caused by the bacterium Borrelia burgdorferi and is transmitted through the bite of infected ticks of the genus Ixodes.
According to the WHO, Lyme disease is more prominent in forested areas of Asia, north-western, central and eastern Europe, and the USA. Visitors to rural areas are more prone to infection with B. burgdorferi. Diagnosis of Lyme disease occurs as a two-tiered test where confirmation of Lyme disease by Western Blot is essential. Reported cases indicate only patients suspected of having Lyme disease, whereas confirmed cases are the patients who tested positive in both diagnostic tests. Lyme Disease Tests is segmented into Lyme Disease Enzyme Immunoassay Test, Lyme Disease Western Blot Test, and Lyme Disease Other Tests.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Lyme Disease Tests and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - PerkinElmer Inc, bioMerieux SA, Meridian Bioscience Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Who should buy this report?
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -